Systemic sclerosis (scleroderma) trials in Estonia
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Tallinn, Tartu Linn
- Age
- 18 years and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00